📰 Marcus News
Page 58 - Marcus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Marcus. Real-time updates on events, politics, business and more.
May 16, 2023
Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating)’s share price was down 7.8% during mid-day trading on Tuesday . The company traded as low as $17.78 and last traded at $17.99. Approximately 387,122 shares changed hands during trading, a decline of 61% from the average daily volume of 999,097 shares. The stock had previously closed at […]
May 15, 2023
Item 1.01 Entry into a Material Definitive Agreement. On May 15, 2023, Arcus Biosciences, Inc. entered into an amendment to its Option, License and Collaboration Agreement with Gilead Sciences,... | May 15, 2023
May 15, 2023
Free agent cornerback Marcus Peters is visiting with the Las Vegas Raiders on Monday as he looks to firm up where he will play in 2023, The Athletic reported.
May 13, 2023
As the temperature rises and summer approaches, Montreal's rooftop bars and terrasses are calling your name. Whether you're looking for a romantic date spot or a lively hangout with friends — Montreal's terrasse scene has got you covered. From sweeping city views to cozy garden vibes, these 15 hotspots are sure to make your summer unforgettable.
May 12, 2023
Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) – Investment analysts at Wedbush dropped their Q2 2023 earnings per share estimates for Arcus Biosciences in a report issued on Wednesday, May 10th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of ($1.23) per share for the quarter, down from their prior estimate […]
May 12, 2023
Late-Breaking Abstract Demonstrates Capabilities of ARCUS for Large Gene Excision In Vivo ... | May 12, 2023
May 12, 2023
In a research note published by Marcus Diebel, JP Morgan gives a Neutral rating to the stock. The target price is still set at EUR 49. | May 12, 2023
May 11, 2023
Analyst Marcus Diebel from JP Morgan research gives the stock a Neutral rating. The target price is unchanged and still at EUR 49. | May 11, 2023
May 11, 2023
Arcus Biosciences (NYSE:RCUS – Get Rating) posted its quarterly earnings data on Tuesday. The company reported ($1.09) earnings per share for the quarter, missing the consensus estimate of ($1.06) by ($0.03), Briefing.com reports. The firm had revenue of $25.00 million for the quarter, compared to analyst estimates of $22.47 million. Arcus Biosciences had a negative […]
May 11, 2023
The Marcus Corporation today announced it will webcast its rescheduled Annual Meeting of Shareholders, which is planned to be held on Tuesday, May 23, 2023, beginning at 9:00 a.m. Central/10:00 a.m.... | May 11, 2023